Inquiry finds flaws in getting informed consent of parents

Image
Press Trust of India New Delhi
Last Updated : Mar 12 2013 | 6:20 PM IST
Government today admitted certain 'flaws' in getting the informed consent of parents or guardians before conducting clinical trials on children in Safdarjung Hospital.
In reply to a question in the Rajya Sabha on National Human Rights Commisssion notice on illegal drug trials in three government hospitals in Delhi, Minister of Health and Family Welfare Ghulam Nabi Azad said his Ministry has sent its reply on March 11 after the matter was examined by three expert committees.
The NHRC had sent the notice on February 7 this year over alleged illegal clinical trials on 3,479 children during the last five years in Delhi's three government hospitals - Safdarjung Hospital, Lok Nayak Jaya Prakash Narayan Hospital and Kalawati Saran Hospital.
Azad said the matter was immediately examined by the Drugs Controller General (India) through three expert committees, each having an expert in the relevant area, an officer from CDSCO and one officer from state drug control department, Delhi.
"On the basis of the report of these committees, the DCG (I), in its report to the Ministry, concluded that the studies at these hospitals were conducted on the children after taking the consent of their guardians/parents. However, in case of Safdarjung Hospital, a few flaws were noted in getting their informed consent," Azad said.
The Health Ministry will ensure that all required measures are taken by DCG(I) "so that only those clinical trials are allowed in future which are strictly as per prescribed norms", the Minister assured the House.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 12 2013 | 6:20 PM IST

Next Story